Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou, China.
Acta Oncol. 2012 Mar;51(3):285-92. doi: 10.3109/0284186X.2011.621447. Epub 2011 Oct 13.
Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24) suppresses growth and induces apoptosis in a broad range of human cancers without significant cytotoxicity to normal cells. Conditionally replicating adenoviruses (CRAds) not only have the ability to destroy cancer cells but may also be potential vectors for the expression of therapeutic genes.
This review provides an overview of specifications for a novel anti-tumor approach CRAds carrying IL-24, and discusses recent progress in this field.
Studies in multiple laboratories report that CRAds carrying IL-24 selectively induced apoptosis in some cancer cells, and enhanced selective toxicity to cancer cells when combined with chemotherapeutic agents.
CRAds carrying IL-24 may prove a novel and effective approach for the treatment of cancers.
黑色素瘤分化相关基因 7/白细胞介素 24(mda-7/IL-24)在广泛的人类癌症中抑制生长并诱导细胞凋亡,而对正常细胞没有明显的细胞毒性。条件复制腺病毒(CRAds)不仅具有破坏癌细胞的能力,而且还可能是治疗基因表达的潜在载体。
本综述概述了携带白细胞介素 24 的新型抗肿瘤方法 CRAds 的特点,并讨论了该领域的最新进展。
多个实验室的研究报告称,携带白细胞介素 24 的 CRAds 选择性地诱导一些癌细胞凋亡,并与化疗药物联合使用时增强了对癌细胞的选择性毒性。
携带白细胞介素 24 的 CRAds 可能成为治疗癌症的一种新的有效方法。